Bayer AG
NDC Database
Bayer AG
NDC Database
National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.
- Total Records 40
- Latest Marketing Date 2026-06-12
- Data Source FDA
- First Marketing Date 1982-12-29
Company Overview
Social Profiles
Company Snapshot
Bayer AG
Mullerstr. 178, 13353 Berlin
Germany
pharma.bayer.com/ pharmachemicals@bayer.com View on MapNDC Records ( 40 records )
Nonproprietary Name
regorafenib
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
REGORAFENIB
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Regorafenib Monohydrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
REGORAFENIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-04-24
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
riociguat
Dosage Form
TABLET, FILM COATED
Strength
0.5 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIOCIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
riociguat
Dosage Form
TABLET, FILM COATED
Strength
1 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIOCIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
riociguat
Dosage Form
TABLET, FILM COATED
Strength
1.5 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIOCIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
riociguat
Dosage Form
TABLET, FILM COATED
Strength
2 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIOCIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
riociguat
Dosage Form
TABLET, FILM COATED
Strength
2.5 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIOCIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Pradofloxacin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
PRADOFLOXACIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2021-08-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pradofloxacin Trihydrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
PRADOFLOXACIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2021-08-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sevabertinib
Dosage Form
TABLET, COATED
Strength
10 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SEVABERTINIB
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-19
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Moxifloxacin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
MOXIFLOXACIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2016-05-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Ciprofloxacin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2016-05-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ciprofloxacin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2016-09-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
finerenone
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FINERENONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-07-09
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Rivaroxaban Microfine
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
RIVAROXABAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2014-05-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
finerenone
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FINERENONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-07-09
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Nifedipine
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
NIFEDIPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2016-10-07
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Enrofloxacin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ENROFLOXACIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2021-08-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
mesalazin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
MESALAMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2013-04-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
praziquantel
Dosage Form
TABLET, FILM COATED
Strength
600 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAZIQUANTEL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1982-12-29
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
vericiguat
Dosage Form
TABLET, FILM COATED
Strength
2.5 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VERICIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-01-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
vericiguat
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VERICIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-01-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
vericiguat
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VERICIGUAT
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-01-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
sorafenib
Dosage Form
TABLET, FILM COATED
Strength
200 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SORAFENIB
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-01
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ciprofloxacin hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1997-09-26
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ciprofloxacin hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1997-08-26
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Estradiol valerate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ESTRADIOL VALERATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-10
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Testosterone enantate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
TESTOSTERONE ENANTHATE
Product Type
BULK INGREDIENT
DEA Schedule
CIII
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levonorgestrel
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
LEVONORGESTREL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-10
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Norgestrel
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
NORGESTREL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
norethisterone
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
NORETHINDRONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Norethisterone acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
NORETHINDRONE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ethinylestradiol
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ETHINYL ESTRADIOL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Estradiol-Hemihydrate Sieved
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ESTRADIOL HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Estradiol benzoate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ESTRADIOL BENZOATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Medroxyprogesterone acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
MEDROXYPROGESTERONE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Ethinylestradiol
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ETHINYL ESTRADIOL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-10
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Estradiol-Hemihydrate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
ESTRADIOL HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Tetsoteron Micronized
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Bayer AG
Marketing Category
BULK INGREDIENT
Substance
TESTOSTERONE
Product Type
BULK INGREDIENT
DEA Schedule
CIII
Start Marketing Date
2017-05-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gadoquatrane
Dosage Form
INJECTION
Strength
257.9 mg/mL
Labeler
Bayer AG
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GADOQUATRANE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-06-12
End Marketing Date
-
Listing Record Certified Through
2027-12-31
NDC Type Breakdown
40 total- Drug for Further Processing
- Bulk Ingredient
Official Source
NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).
Visit FDA NDC DirectoryNDC Record Details Preview
Explore important National Drug Code information available in the records above.
NDC
12527-0171
Nonproprietary Name
regorafenib
Labeler
Bayer AG
Dosage Form
TABLET, FILM COATED
FDA NDC Data
National Drug Code information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized NDC records
Create a New Buying Request
Fields marked with * are mandatory.